Abstract
In 2015, the Colorectal Cancer (CRC) Subtyping Consortium published four gene expression consensus molecular subtypes (CMS) from early stage CRC patients: CMS1 (immune), CMS2 (canonical), CMS3 (metabolic), and CMS4 (mesenchymal). The distribution of CMS groups is not well described for late-stage CRC.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
